Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evaluating reduced effectiveness after repeat influenza vaccination while accounting for confounding by recent infection and within-season waning

Qifang Bi, Barbra A. Dickerman, Huong Q. McLean, Emily T. Martin, Manjusha Gaglani, Karen J. Wernli, Balasubramani Goundappa, Brendan Flannery, Marc Lipsitch, Sarah Cobey, the US Flu Vaccine Effectiveness Network Investigators
doi: https://doi.org/10.1101/2023.03.12.23287173
Qifang Bi
1University of Chicago
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: qifang.bi@gmail.com
Barbra A. Dickerman
2Harvard T.H. Chan School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huong Q. McLean
3Marshfield Clinic Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily T. Martin
4University of Michigan School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manjusha Gaglani
5Baylor Scott & White Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen J. Wernli
6Kaiser Permanente Washington Health Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Balasubramani Goundappa
7University of Pittsburgh School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brendan Flannery
8Centers for Disease Control and Prevention
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Lipsitch
2Harvard T.H. Chan School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Cobey
1University of Chicago
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

1 Abstract

Background Studies have reported that prior-season influenza vaccination is associated with higher risk of clinical influenza infection among vaccinees in a given season. Understanding the underlying causes requires consideration of within-season waning and recent infection.

Methods Using the US Flu Vaccine Effectiveness (VE) Network data over 8 influenza seasons (2011-2012 to 2018-2019), we estimated the effect of prior-season vaccination on the odds of clinical infection in a given season, after accounting for waning vaccine protection using regression methods. We adjusted for potential confounding by recent clinical infection using inverse-probability weighting. We investigated theoretically whether unmeasured subclinical infection in the prior season, which is more likely in the non-repeat vaccinees, could explain the repeat vaccination effect.

Results Repeat vaccinees vaccinated earlier in a season by one week. After accounting for waning VE, repeat vaccinees were still more likely to test positive for influenza A(H3N2) (OR=1.11, 95% CI:1.02-1.21) but not for influenza B (OR=1.03, 95% CI:0.89-1.18) or A(H1N1) (OR=1.03, 95% CI:0.90-1.19) compared to those vaccinated in the given season only. Recent clinical infection with the homologous (sub)type protected against clinical infection with A(H3N2) or B. Individuals with clinical infection in one season had 1.11 (95% CI:1.03-1.19) times the odds of switching vaccination status in the following season. Adjusting for recent clinical infections did not strongly influence the estimated effect of prior-season vaccination. Adjusting for subclinical infection could theoretically attenuate this effect.

Conclusion Waning protection and recent clinical infection were insufficient to explain observed reduced VE in repeat vaccinees with a test-negative design.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was partially supported by the Collaborative Influenza Vaccine Innovation Centers (CIVICs) contract 75N93019C00051 (S.C. and Q.B.). ML acknowledges support from US NIH grant 1R01GM139926 to University of Michigan.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee of the University of Chicago gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • ↵** Study group team members are listed in the acknowledgements.

Data Availability

Data and relevant code are available at https://github.com/cobeylab/FluVE_repeatvac_public

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 17, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evaluating reduced effectiveness after repeat influenza vaccination while accounting for confounding by recent infection and within-season waning
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluating reduced effectiveness after repeat influenza vaccination while accounting for confounding by recent infection and within-season waning
Qifang Bi, Barbra A. Dickerman, Huong Q. McLean, Emily T. Martin, Manjusha Gaglani, Karen J. Wernli, Balasubramani Goundappa, Brendan Flannery, Marc Lipsitch, Sarah Cobey, the US Flu Vaccine Effectiveness Network Investigators
medRxiv 2023.03.12.23287173; doi: https://doi.org/10.1101/2023.03.12.23287173
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Evaluating reduced effectiveness after repeat influenza vaccination while accounting for confounding by recent infection and within-season waning
Qifang Bi, Barbra A. Dickerman, Huong Q. McLean, Emily T. Martin, Manjusha Gaglani, Karen J. Wernli, Balasubramani Goundappa, Brendan Flannery, Marc Lipsitch, Sarah Cobey, the US Flu Vaccine Effectiveness Network Investigators
medRxiv 2023.03.12.23287173; doi: https://doi.org/10.1101/2023.03.12.23287173

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (238)
  • Allergy and Immunology (519)
  • Anesthesia (124)
  • Cardiovascular Medicine (1406)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (580)
  • Epidemiology (10263)
  • Forensic Medicine (6)
  • Gastroenterology (525)
  • Genetic and Genomic Medicine (2611)
  • Geriatric Medicine (253)
  • Health Economics (495)
  • Health Informatics (1727)
  • Health Policy (788)
  • Health Systems and Quality Improvement (669)
  • Hematology (266)
  • HIV/AIDS (563)
  • Infectious Diseases (except HIV/AIDS) (12066)
  • Intensive Care and Critical Care Medicine (647)
  • Medical Education (272)
  • Medical Ethics (83)
  • Nephrology (286)
  • Neurology (2448)
  • Nursing (143)
  • Nutrition (374)
  • Obstetrics and Gynecology (486)
  • Occupational and Environmental Health (565)
  • Oncology (1314)
  • Ophthalmology (397)
  • Orthopedics (145)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (341)
  • Pediatrics (776)
  • Pharmacology and Therapeutics (328)
  • Primary Care Research (294)
  • Psychiatry and Clinical Psychology (2390)
  • Public and Global Health (4987)
  • Radiology and Imaging (892)
  • Rehabilitation Medicine and Physical Therapy (520)
  • Respiratory Medicine (680)
  • Rheumatology (307)
  • Sexual and Reproductive Health (253)
  • Sports Medicine (244)
  • Surgery (296)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)